Association between GDF-15 levels and changes in vascular and physical function in older patients with hypertension

Aging Clin Exp Res. 2017 Oct;29(5):1055-1059. doi: 10.1007/s40520-016-0636-0. Epub 2016 Oct 12.

Abstract

Background: Growth differentiation factor-15 (GDF-15) may be a biomarker of disease, protective response and/or prognosis, in older people with hypertension.

Aims: To correlate baseline GDF-15 levels with physical and vascular health data in this population.

Methods: Baseline blood samples were analysed using a GDF-15 ELISA assay kit. Correlations with baseline and 12-month outcome data, including measures of physical and vascular function, were performed.

Results: A total of 147 individuals, mean age 76.8 ± 4.7 years, were included. 77 (52 %) were male. Baseline log10GDF-15 showed significant correlations with age (r = 0.37, p < 0.001), total cholesterol (r = -0.33, p < 0.001) and 6-min walking distance (r = -0.37, p < 0.001). Age remained significantly associated with log10GDF-15 in multivariable analysis (beta = -0.29, p = 0.001). Baseline log10GDF-15 was significantly associated with decline in 6-min walk distance over 12 months (beta = -0.27, p = 0.01) in multivariable models. No significant correlations were seen with changes in vascular function over 12 months.

Conclusion: Baseline GDF-15 predicts declining physical, but not vascular, function in our population.

Keywords: Ageing; Biomarker; Cardiovascular disease; Frailty; Inflammation.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Aging / physiology*
  • Biomarkers / blood
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Growth Differentiation Factor 15 / blood*
  • Humans
  • Hypertension / blood*
  • Hypertension / physiopathology
  • Male
  • Multivariate Analysis
  • Walking / physiology

Substances

  • Biomarkers
  • GDF15 protein, human
  • Growth Differentiation Factor 15